Localized small-cell lung cancer: which type of thoracic radiotherapy and which time schedule
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference17 articles.
1. Effect of cancer chemotherapeutic drugs on radiation-induced Lung damage in mice;Von der Maase;Radiother OncoL,1986
2. Pulmonary toxicity with combined modality therapy for Limited stage small cell Lung cancer;Brooks;J Clin Oncol,1986
3. Takada M, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for Limited-stage small-cell Lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 202;20:3054–60.
4. Do elderly patients with locally advanced non-small cell Lung cancer benefit from combined modality therapy? A secondary analysis of RTOG 94-10;Langer;Int J Radiat Oncol Biol Phys,2001
5. Beta blockade during and after myocardial infraction: an overview of the randomised trials;Yusuf;Prog Cardiovasc Dis,1985
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development of generalized time-dependent TCP model and the investigation of the effect of repopulation and weekend breaks in fractionated external beam therapy;Journal of Theoretical Biology;2021-03
2. The influence of time of radio-chemotherapy and other therapeutic factors on treatment results in patients with limited disease small cell lung cancer;Lung Cancer;2013-01
3. Hyperfractionated or Accelerated Radiotherapy in Lung Cancer: An Individual Patient Data Meta-Analysis;Journal of Clinical Oncology;2012-08-01
4. Concurrent hyperfractionated radiotherapy and chemotherapy for patients with limited small-cell lung cancer. Results from a single institution;Reports of Practical Oncology & Radiotherapy;2009-03
5. Accelerated hyperfractionated radiotherapy and concomitant chemotherapy in small cell lung cancer limited-disease. Dose response, feasibility and outcome for patients treated in western Sweden, 1998–2004.;Acta Oncologica;2007-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3